Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.

F. Stephen Hodi, Steven J. O'Day, David F. McDermott, Robert W. Weber, Jeffrey A. Sosman, John B. Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J.M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M. Vaubel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael J. Yellin, Geoffrey M. Nichol, Axel Hoos, Walter J. Urba, Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. The New England Journal of Medicine. ,vol. 363, pp. 711- 723 ,(2010) , 10.1056/NEJMOA1003466

Robbie B. Mailliard, Anna Wankowicz-Kalinska, Quan Cai, Amy Wesa, Catharien M. Hilkens, Martien L. Kapsenberg, John M. Kirkwood, Walter J. Storkus, Pawel Kalinski, alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Research. ,vol. 64, pp. 5934- 5937 ,(2004) , 10.1158/0008-5472.CAN-04-1261

Eva Lion, Evelien L.J.M. Smits, Zwi N. Berneman, Viggo F.I. Van Tendeloo, NK Cells: Key to Success of DC‐Based Cancer Vaccines? The Oncologist. ,vol. 17, pp. 1256- 1270 ,(2012) , 10.1634/THEONCOLOGIST.2011-0122

Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small, David F. Penson, Charles H. Redfern, Anna C. Ferrari, Robert Dreicer, Robert B. Sims, Yi Xu, Mark W. Frohlich, Paul F. Schellhammer, Sipuleucel-T immunotherapy for castration-resistant prostate cancer. The New England Journal of Medicine. ,vol. 363, pp. 411- 422 ,(2010) , 10.1056/NEJMOA1001294

Amin E. Moghaddam, Kate H. Gartlan, Leopold Kong, Quentin J. Sattentau, Reactive Carbonyls Are a Major Th2-Inducing Damage-Associated Molecular Pattern Generated by Oxidative Stress Journal of Immunology. ,vol. 187, pp. 1626- 1633 ,(2011) , 10.4049/JIMMUNOL.1003906

Iulia Diaconu, Vincenzo Cerullo, Mari L.M. Hirvinen, Sophie Escutenaire, Matteo Ugolini, Saila K. Pesonen, Simona Bramante, Suvi Parviainen, Anna Kanerva, Angelica S.I. Loskog, Aristides G. Eliopoulos, Sari Pesonen, Akseli Hemminki, Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus Cancer Research. ,vol. 72, pp. 2327- 2338 ,(2012) , 10.1158/0008-5472.CAN-11-2975

Cheryl L-L Chiang, Jonathan A Ledermann, Ariel N Rad, David R Katz, Benjamin M Chain, None, Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells Cancer Immunology, Immunotherapy. ,vol. 55, pp. 1384- 1395 ,(2006) , 10.1007/S00262-006-0127-9

Jacques Banchereau, Francine Briere, Christophe Caux, Jean Davoust, Serge Lebecque, Yong-Jun Liu, Bali Pulendran, Karolina Palucka, Immunobiology of Dendritic Cells Annual Review of Immunology. ,vol. 18, pp. 767- 811 ,(2000) , 10.1146/ANNUREV.IMMUNOL.18.1.767

Hideki Ueno, Nathalie Schmitt, Eynav Klechevsky, Alexander Pedroza-Gonzalez, Toshimichi Matsui, Gerard Zurawski, SangKon Oh, Joseph Fay, Virginia Pascual, Jacques Banchereau, Karolina Palucka, Harnessing human dendritic cell subsets for medicine Immunological Reviews. ,vol. 234, pp. 199- 212 ,(2010) , 10.1111/J.0105-2896.2009.00884.X

Hiroaki Kanaya, Theresa L. Whiteside, Grzegorz Dworacki, Norbert Meidenbauer, Thomas K. Hoffmann, Generation of Tumor-specific T Lymphocytes by Cross-Priming with Human Dendritic Cells Ingesting Apoptotic Tumor Cells Cancer Research. ,vol. 60, pp. 3542- 3549 ,(2000)